NO173501C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser

Info

Publication number
NO173501C
NO173501C NO895165A NO895165A NO173501C NO 173501 C NO173501 C NO 173501C NO 895165 A NO895165 A NO 895165A NO 895165 A NO895165 A NO 895165A NO 173501 C NO173501 C NO 173501C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
pyridine compounds
analogous procedures
active pyrazolo
Prior art date
Application number
NO895165A
Other languages
English (en)
Norwegian (no)
Other versions
NO173501B (no
NO895165L (no
NO895165D0 (no
Inventor
Yoshihiro Fujikawa
Mikio Suzuki
Hiroshi Iwasaki
Mitsuaki Sakashita
Masaki Kitahara
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of NO895165L publication Critical patent/NO895165L/no
Publication of NO895165D0 publication Critical patent/NO895165D0/no
Publication of NO173501B publication Critical patent/NO173501B/no
Publication of NO173501C publication Critical patent/NO173501C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
NO895165A 1988-04-26 1989-12-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser NO173501C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP10309088 1988-04-26
JP27143988 1988-10-27
JP1684689 1989-01-26
PCT/JP1989/000423 WO1989010365A1 (en) 1988-04-26 1989-04-19 Pyrazolopyridine type mevalonolactones

Publications (4)

Publication Number Publication Date
NO895165L NO895165L (no) 1989-12-21
NO895165D0 NO895165D0 (no) 1989-12-21
NO173501B NO173501B (no) 1993-09-13
NO173501C true NO173501C (no) 1993-12-22

Family

ID=27281590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895165A NO173501C (no) 1988-04-26 1989-12-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser

Country Status (10)

Country Link
EP (1) EP0339358B1 (de)
JP (1) JP2890448B2 (de)
KR (1) KR970009222B1 (de)
AT (1) ATE108450T1 (de)
DE (1) DE68916685T2 (de)
DK (1) DK659089D0 (de)
FI (1) FI90870C (de)
HU (1) HU203888B (de)
NO (1) NO173501C (de)
WO (1) WO1989010365A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3130342B2 (ja) * 1991-10-04 2001-01-31 日産化学工業株式会社 動脈硬化性血管内膜肥厚抑制薬
WO2001072749A1 (en) * 2000-03-27 2001-10-04 Takeda Chemical Industries, Ltd. Condensed pyrazole derivatives, process for producing the same and use thereof
US20100210644A1 (en) * 2007-06-25 2010-08-19 Boehringer Ingelheim International Gmbh Chemical compounds
TW200924762A (en) 2007-11-02 2009-06-16 Vertex Pharma Kinase inhibitors
EP2867236B1 (de) 2012-06-29 2017-06-14 Pfizer Inc Neue 4-(substituierte amino)-7h-pyrrolo[2,3-d]pyrimidine als lrrk2 hemmer
EP3083618B1 (de) 2013-12-17 2018-02-21 Pfizer Inc Neuartige 3,4-disubstituierte-1h-pyrrolo[2,3-b]pyridine und 4,5-disubstituierte 7h-pyrrolo[2,3-c]pyridazine als lrrk2-hemmer
RU2722149C1 (ru) 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
US12583852B2 (en) 2018-05-02 2026-03-24 Jw Pharmaceutical Corporation Heterocycle derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
ATE62906T1 (de) * 1984-06-22 1991-05-15 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals

Also Published As

Publication number Publication date
FI90870B (fi) 1993-12-31
ATE108450T1 (de) 1994-07-15
NO173501B (no) 1993-09-13
DK659089A (da) 1989-12-22
NO895165L (no) 1989-12-21
HU203888B (en) 1991-10-28
NO895165D0 (no) 1989-12-21
FI90870C (fi) 1994-04-11
WO1989010365A1 (en) 1989-11-02
FI896251A0 (fi) 1989-12-22
JP2890448B2 (ja) 1999-05-17
HU892751D0 (en) 1990-03-28
DK659089D0 (da) 1989-12-22
JPH02275878A (ja) 1990-11-09
EP0339358B1 (de) 1994-07-13
DE68916685T2 (de) 1995-02-09
DE68916685D1 (de) 1994-08-18
KR900700480A (ko) 1990-08-13
KR970009222B1 (ko) 1997-06-09
EP0339358A1 (de) 1989-11-02

Similar Documents

Publication Publication Date Title
NO173824C (no) Analogifremgangsmaate ved fremstilling av immunomodulerende azaspiraner
NZ329374A (en) Tricyclic amide and urea derivatives, preparation thereof
NL300298I2 (nl) Nieuwe 3-piperidinyl-1,2-benzisoxazolen
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
NO904134L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
FI885594A0 (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
NO902301D0 (no) Fremgangsmaate for fremstilling av diarylstyrylkinolin-disyrer.
HU9301197D0 (en) Medical preparatives containing quinoline and quinazoline derivatives as well as new quinoline and quinazoline derivatives
IL99829A0 (en) Heteroaroyl derivatives of monocyclic beta-lactams,pharmaceutical compositions containing the same and processes for the preparation thereof
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
NO173501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser
IL107321A0 (en) Substituted azetidinones, their preparation and pharmaceutical compositions comprising them
CA2095361A1 (en) Optical isomers of 7-¬3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl|-quinolones and naphthyridones as antibacterial agents
ATE178328T1 (de) Loracarbef isopropanolat und umwandlungsverfahren vom isopropanolat in loracarbef monohydrat
NO942048L (no) Fremgangsmåte for fremstilling av krystallinsk loracarbef-monohydrat
FI103885B (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
IT1247921B (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono